Clinical Trial Results: Omega-3 Fatty Acids for Smoking Cessation in Pregnancy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing omega-3 fatty acids for smoking cessation in pregnancy completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Labor
• Tobacco Use Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Preterm Labor, Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2026-06-04